NASDAQ$ESTA
Establishment Labs Holdings Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Reported record second quarter financial results and raised full year guidance.
Establishment Labs reported a record second quarter revenue of $32.0 million, a 205% increase year-over-year. The company raised its full year 2021 revenue guidance to a new range of $122 million to $126 million.
- Second quarter worldwide sales reached $32.0 million, a 205% increase year-over-year.
- 2021 guidance increased to a new range of $122 million to $126 million, representing a 44% to 49% increase over 2020.
- Second quarter operating expenses were $26.1 million, a 55% increase compared to the second quarter of 2020.
- Total net cash burn was $1.1 million in the second quarter, with a cash balance of $76.8 million as of June 30, 2021.
Headline financials
Revenue & EPS history
Establishment Labs · Revenue · Quarterly
$32M
Forward guidance
The company raised its full year 2021 revenue guidance to a new range of $122 million to $126 million.
Tailwinds
- Strong second quarter revenue growth of 205% year-over-year.
- Increased full year 2021 revenue guidance.
- Publication of landmark study showing superior biocompatibility of Motiva® SmoothSilk® implant technology.
- Expanding marketing and commercial activities with Motiva Ergonomix2®.
- Continuing commercial launch of Motiva Flora® tissue expander in Europe.
Headwinds
- Ongoing challenges from the pandemic.
- Net loss from operations for the second quarter was $5.3 million.
- Cash decreased $7.7 million from December 31, 2020.
- Total operating expenses for the second quarter were $26.1 million.
- R&D expenses increased approximately $2.0 million to $4.3 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+1.5%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+2.4%
Avg return
30 days after
56%
18 / 32 earnings
Positive
+22.5%
Q3 2025
Best reaction
-26.0%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -4.3% | +2.9% | |
| Q4 2025 | -1.9% | +5.0% | -20.1% | |
| Q3 2025 | +22.5% | +37.0% | +43.2% | |
| Q1 2025 | +4.9% | +5.1% | +14.2% | |
| Q4 2024 | +17.9% | +28.1% | +12.1% | |
| Q3 2024 | -5.2% | -13.2% | -10.0% | |
| Q2 2024 | +3.4% | +20.6% | +23.5% | |
| Q1 2024 | +5.4% | +4.2% | -10.8% | |
| Q4 2023 | +15.1% | +19.6% | +28.2% | |
| Q3 2023 | -26.0% | -36.1% | -31.7% | |
| Q2 2023 | -8.4% | -12.0% | -12.2% | |
| Q1 2023 | +1.8% | -1.6% | -1.9% | |
| Q4 2022 | +7.2% | +10.3% | +0.3% | |
| Q3 2022 | -7.7% | +11.1% | +27.1% | |
| Q2 2022 | -3.0% | +1.3% | -0.4% | |
| Q1 2022 | -10.5% | -10.1% | +2.3% | |
| Q4 2021 | +3.3% | +1.6% | +11.5% | |
| Q3 2021 | -10.6% | -14.3% | -15.2% | |
| Q2 2021 | +6.0% | -3.7% | -3.1% | |
| Q1 2021 | -0.6% | -1.8% | +8.9% | |
| Q4 2020 | +0.4% | -6.8% | +9.5% | |
| Q3 2020 | +8.9% | -0.4% | +22.6% | |
| Q2 2020 | +6.2% | +7.3% | +9.3% | |
| Q1 2020 | +2.9% | +0.5% | +15.3% | |
| Q4 2019 | +4.5% | -16.4% | +0.4% | |
| Q3 2019 | -0.3% | +0.5% | +7.8% | |
| Q2 2019 | -5.2% | -10.6% | -10.2% | |
| Q1 2019 | +1.5% | -0.3% | -15.9% | |
| Q4 2018 | -1.9% | -4.9% | -15.2% | |
| Q3 2017 | +10.3% | +4.5% | -6.2% | |
| Q3 2018 | +10.3% | +4.5% | -6.2% | |
| Q2 2018 | -2.7% | -2.9% | -3.4% | |
| Q4 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro